tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsTools for Trading PlatformsData for Hedge FundsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

BMY Stock Latest News

Bristol Myers Squibb put volume heavy and directionally bearish
The FlyBristol Myers Squibb put volume heavy and directionally bearish
11d ago
BMY
Cantor biopharma/biotech analysts to hold analyst/industry conference call
The FlyCantor biopharma/biotech analysts to hold analyst/industry conference call
12d ago
BMY
AMGN
Cantor biopharma/biotech analysts to hold analyst/industry conference call
The FlyCantor biopharma/biotech analysts to hold analyst/industry conference call
13d ago
BMY
AMGN
Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
The FlyStreet Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
15d ago
BMY
AAPL
Jefferies starts ‘optically cheap’ Bristol-Myers at Hold on structural concerns
The FlyJefferies starts ‘optically cheap’ Bristol-Myers at Hold on structural concerns
16d ago
BMY
Bristol-Myers initiated with a Hold at Jefferies
The FlyBristol-Myers initiated with a Hold at Jefferies
16d ago
BMY
Cantor biopharma/biotech analysts to hold analyst/industry conference call
The FlyCantor biopharma/biotech analysts to hold analyst/industry conference call
16d ago
BMY
AMGN
Bristol-Myers receives EC approval of Reblozyl
The FlyBristol-Myers receives EC approval of Reblozyl
19d ago
BMY
Bristol-Myers and Johnson & Johnson launch Phase 3 trial of milvexian
The FlyBristol-Myers and Johnson & Johnson launch Phase 3 trial of milvexian
20d ago
BMY
JNJ
Bristol-Myers: FDA accepts sBLA for Opdivo
The FlyBristol-Myers: FDA accepts sBLA for Opdivo
22d ago
BMY
Bristol Myers Squibb put volume heavy and directionally bearish
The FlyBristol Myers Squibb put volume heavy and directionally bearish
25d ago
BMY
Bristol-Myers announces three-year results from Phase 3 CheckMate-274 trial
The FlyBristol-Myers announces three-year results from Phase 3 CheckMate-274 trial
1M ago
BMY
Bristol-Myers’ Opdivo and Exelixis’ Cabometyx show durable survival in carcinoma
The FlyBristol-Myers’ Opdivo and Exelixis’ Cabometyx show durable survival in carcinoma
1M ago
BMY
EXEL
Bristol-Myers, 2seventy Bio present results from KarMMa-3 studyof Abecma
The FlyBristol-Myers, 2seventy Bio present results from KarMMa-3 studyof Abecma
1M ago
BMY
TSVT
Bristol-Myers CEO sells $17.9M in common stock
The FlyBristol-Myers CEO sells $17.9M in common stock
1M ago
BMY
Pharma Earnings: Q4 Hits and Misses in a Post-COVID-19 World
Market NewsPharma Earnings: Q4 Hits and Misses in a Post-COVID-19 World
2M ago
BMY
LLY
Exscientia announces 1st- in-human trial for Bristol-Myers in-licensed EXS4318
The FlyExscientia announces 1st- in-human trial for Bristol-Myers in-licensed EXS4318
2M ago
BMY
EXAI
Bristol-Myers sees FY23 adjusted EPS $7.95-$8.25, consensus $8.00
The FlyBristol-Myers sees FY23 adjusted EPS $7.95-$8.25, consensus $8.00
2M ago
BMY
Bristol-Myers reports Q4 adjusted EPS $1.82, consensus $1.72
The FlyBristol-Myers reports Q4 adjusted EPS $1.82, consensus $1.72
2M ago
BMY
Notable companies reporting before tomorrow’s open
The FlyNotable companies reporting before tomorrow’s open
2M ago
BMY
CAH
Notable companies reporting before tomorrow’s open
The FlyNotable companies reporting before tomorrow’s open
2M ago
BMY
CAH
Prothena reports ‘positive’ topline Phase 1 study results for PRX005
The FlyProthena reports ‘positive’ topline Phase 1 study results for PRX005
2M ago
BMY
PRTA
Bristol-Myers announces CHMP opinion recommending approval for Reblozyl
The FlyBristol-Myers announces CHMP opinion recommending approval for Reblozyl
2M ago
BMY
Bristol-Myers’ Sotyktu recommended for approval in psoriasis by Europe’s CHMP
The FlyBristol-Myers’ Sotyktu recommended for approval in psoriasis by Europe’s CHMP
2M ago
BMY
iVexSol closes $23.8M Series A-3 financing
The FlyiVexSol closes $23.8M Series A-3 financing
2M ago
BMY
CRL
Bristol-Myers reports TRANSCEND CLL 004 trial of Breyanzi met primary endpoint
The FlyBristol-Myers reports TRANSCEND CLL 004 trial of Breyanzi met primary endpoint
2M ago
BMY
Celgene treatment of follicular lymphoma granted FDA orphan designation
The FlyCelgene treatment of follicular lymphoma granted FDA orphan designation
2M ago
BMY
Truist healthcare analysts to hold an analyst/industry conference call
The FlyTruist healthcare analysts to hold an analyst/industry conference call
2M ago
BMY
CYTK
Truist healthcare analysts to hold an analyst/industry conference call
The FlyTruist healthcare analysts to hold an analyst/industry conference call
2M ago
BMY
CYTK